B

Bavarian Nordic A/S
CSE:BAVA

Watchlist Manager
Bavarian Nordic A/S
CSE:BAVA
Watchlist
Price: 190.05 DKK -4.11% Market Closed
Market Cap: 14.9B DKK
Have any thoughts about
Bavarian Nordic A/S?
Write Note

Bavarian Nordic A/S
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bavarian Nordic A/S
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
B
Bavarian Nordic A/S
CSE:BAVA
Tax Provision
-kr8.2m
CAGR 3-Years
-11%
CAGR 5-Years
-9%
CAGR 10-Years
16%
Genmab A/S
CSE:GMAB
Tax Provision
-kr2B
CAGR 3-Years
-53%
CAGR 5-Years
-104%
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Tax Provision
kr4.6m
CAGR 3-Years
N/A
CAGR 5-Years
-20%
CAGR 10-Years
14%
Ascendis Pharma A/S
NASDAQ:ASND
Tax Provision
-€9.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
Fluoguide AS
STO:FLUO
Tax Provision
kr5.5m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Tax Provision
kr5.4m
CAGR 3-Years
-2%
CAGR 5-Years
15%
CAGR 10-Years
18%
No Stocks Found

Bavarian Nordic A/S
Glance View

Market Cap
14.8B DKK
Industry
Biotechnology

Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate cancer, including PROSTVAC and Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) PRO; breast cancer, providing CV-301 breast and MVA-BN HER2 vaccines; and colorectal cancer, offering CV-301 colon. The Infectious Disease pipeline produces vaccines for a range of illnesses, such as smallpox, anthrax, filoviruses, foot-and-mouth diseases and respiratory syncytial virus. The firm is a parent of Bavarian Nordic GmbH, BN Infectious Diseases A/S, and Bavarian Nordic Inc, among others.

BAVA Intrinsic Value
169.64 DKK
Overvaluation 11%
Intrinsic Value
Price
B

See Also

What is Bavarian Nordic A/S's Tax Provision?
Tax Provision
-8.2m DKK

Based on the financial report for Jun 30, 2024, Bavarian Nordic A/S's Tax Provision amounts to -8.2m DKK.

What is Bavarian Nordic A/S's Tax Provision growth rate?
Tax Provision CAGR 10Y
16%

Over the last year, the Tax Provision growth was 54%. The average annual Tax Provision growth rates for Bavarian Nordic A/S have been -11% over the past three years , -9% over the past five years , and 16% over the past ten years .

Back to Top